Skip to main content

Animations

MJFF Publications

511 - 520 of 6082 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-63130-8
    Citation Count: 6
  • Summary Details
    OPEN
    Title: An immersive virtual reality shopping task detects declines in instrumental activities of daily living in individuals with Parkinson’s disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107019
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Genetic analysis and natural history of Parkinson’s disease due to the LRRK2 G2019S variant
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/brain/awae073
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Occupational Pesticide Exposure in Parkinson’s Disease Related to GBA and LRRK2 Variants
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-240015
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissue
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2024.2356490
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Exploring the role of underrepresented populations in polygenic risk scores for neurodegenerative disease risk prediction
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2024.1380860
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Profiling complex repeat expansions in RFC1 in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-024-00723-0
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Association of body mass index with rapid eye movement sleep behavior disorder in Parkinson’s disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1388131
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Epistatic Features and Machine Learning Improve Alzheimer’s Disease Risk Prediction Over Polygenic Risk Scores
    Journal Name: Journal of Alzheimer’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jad-230236
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Impulse control disorders and use of dopamine agonists in early onset Parkinson’s disease
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2024.1404904
    Citation Count: 4
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.